Goldenwell Biotech (Goldenwell Biotech) EV-to-EBIT : -169.05 (As of May. 17, 2024)

Goldenwell Biotech EV-to-EBIT Chart

Goldenwell Biotech Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial									-29.63	-29.58	-29.60	-24.35	-49.13

Competitive Comparison of Goldenwell Biotech's EV-to-EBIT

For the Packaged Foods subindustry, Goldenwell Biotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Goldenwell Biotech's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Goldenwell Biotech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Goldenwell Biotech's EV-to-EBIT falls into.

Goldenwell Biotech EV-to-EBIT Calculation

Goldenwell Biotech's EV-to-EBIT for today is calculated as:

Goldenwell Biotech's current Enterprise Value is $19.78 Mil.
Goldenwell Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Goldenwell Biotech  (OTCPK:GWLL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Goldenwell Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Goldenwell Biotech's Enterprise Value for the quarter that ended in Dec. 2023 was $5.75 Mil.
Goldenwell Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Goldenwell Biotech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Goldenwell Biotech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Goldenwell Biotech (Goldenwell Biotech) Business Description